224 related articles for article (PubMed ID: 22504387)
1. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
2. Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma.
Lin CJ; Lim KH; Cheng YC; Chen HH; Wu CJ
Med Oncol; 2007; 24(4):455-7. PubMed ID: 17917099
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
4. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
5. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
6. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome following a single dose of capecitabine.
Kurt M; Eren OO; Engin H; Güler N
Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470
[No Abstract] [Full Text] [Related]
8. Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Alberts SR; Schroeder M; Erlichman C; Steen PD; Foster NR; Moore DF; Rowland KM; Nair S; Tschetter LK; Fitch TR
J Clin Oncol; 2004 Dec; 22(24):4944-50. PubMed ID: 15611509
[TBL] [Abstract][Full Text] [Related]
9. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
Biswas S; Nik S; Corrie PG
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and cancer of the pancreas: new preparation. Helpful or not?
Prescrire Int; 1999 Jun; 8(41):74-5. PubMed ID: 10558444
[TBL] [Abstract][Full Text] [Related]
11. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Heinemann V
J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
[No Abstract] [Full Text] [Related]
12. Cutaneous metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case treated with gemcitabine.
Takemura N; Fujii N; Tanaka T
J Dermatol; 2007 Sep; 34(9):662-4. PubMed ID: 17727372
[No Abstract] [Full Text] [Related]
13. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
[No Abstract] [Full Text] [Related]
14. [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].
Shitara K; Ishiguro A; Munakata M; Sakata Y; Hirata N; Yabu K; Wada R
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1981-4. PubMed ID: 16282740
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
Saadati H; Saif MW
JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
[No Abstract] [Full Text] [Related]
16. First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer.
Saif MW; Chakerian P; Kaley K; Lamb L
JOP; 2010 May; 11(3):273-4. PubMed ID: 20442527
[No Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Maisonneuve P; Lowenfels AB
JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
[No Abstract] [Full Text] [Related]
18. Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?
Moreau E; André N; Coze C; Padovani L; Mercier C; Ciccolini J
Pediatr Blood Cancer; 2010 May; 54(5):781-2. PubMed ID: 20205259
[No Abstract] [Full Text] [Related]
19. Congestive heart failure secondary to gemcitabine nab-paclitaxel in patients with pancreatic cancer.
John P; Butler H; Saif MW
Anticancer Res; 2014 Dec; 34(12):7267-70. PubMed ID: 25503159
[TBL] [Abstract][Full Text] [Related]
20. [Gemcitabine treatment of pancreatic cancer peritonitis].
Horiki N; Maruyama M; Fujita Y; Suzuki Y; Tanaka T; Shimomura M; Tanigawa K; Sasaki H; Fujiwara M; Suzuki K; Imoto I; Adachi Y
Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):73-8. PubMed ID: 12601933
[No Abstract] [Full Text] [Related]
[Next] [New Search]